DLL4 and neoplasm: Emerging new approaches that target the Notch signaling ligand DLL4 result in excessive non-productive angiogenesis, affecting both tumor growth and metastatic behavior in tumors that are refractive to anti-VEGF therapies, although off-target effects are possible (52).